Skip to main content
. 2020 Apr 2;35(7):1282–1288. doi: 10.1002/jbmr.4006

Table 2.

Subjects and Controls Exhibiting Modeling‐Based Bone Formation

Historical controls (N = 11) Denosumab subjects (N = 4)
Modeling‐based fluorochrome labeling at the femoral neck, n (%)
Cancellous 9 (81.8) 4 (100.0)
Endocortical 9 (81.8) 4 (100.0)
Periosteal 11 (100.0) 4 (100.0)

N = number of subjects with an evaluable biopsy for fluorochrome labeling; n = number of subjects with observed data.